Jay Hoofnagle is director of the Liver Disease Research Branch at the National Institute of Diabetes and Digestive and Kidney Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jay Hoofnagle. (2020). Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005913&aid=10.1056%2FNEJMp2031110&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

Los médicos tardan en usar antibióticos nuevos y efectivos contra las superbacterias.

Los médicos tardan en usar antibióticos nuevos y…

New test can identify dangerous bacteria with resistance to last-resort antibiotic

New research suggests it is possible to quickly…

Sask. doctor worries about health system as Omicron numbers rise

Sask. doctor worries about health system as…

Obesity protects against death in severe bacterial infection

According to Science Daily, a new study shows…

Antibiotic resistance: World on cusp of ‘post antibiotic era’

The world is on the cusp of a “post-antibiotic…

Knee replacement in folks over 80: Less risky than you think

Knee replacement in folks over 80: Less risky…

ChatGPT Health: la nueva apuesta de OpenAI para consultas de salud

¿Una consulta médica con ChatGPT? La empresa…